H-Leu-Ser-Lys-Leu-OH
LSYL (H-Leu-Ser-Lys-Leu-OH) is a latency-associated peptide-derived sequence that inhibits TGF-β1 activation by binding to KRFK. This blockade of TGF-β signaling has been shown to suppress hepatic damage and fibrosis progression in research models, making it a tool for studying liver disease and fibrotic pathways.
Product Specifications
Field of Research
Stem Cell & Developmental Biology
Molecular Weight
459.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog